132
Views
54
CrossRef citations to date
0
Altmetric
Article

Mast cells and eosinophils have a potential profibrogenic role in Crohn disease

, , , , &
Pages 440-447 | Received 07 Nov 2003, Accepted 26 Nov 2003, Published online: 08 Jul 2009

References

  • Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182–205.
  • Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. I Paracrine cells important in health and disease. Am J Physiol 1999;277:C1–9.
  • Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. II Intestinal subepithelial myofibroblasts. Am J Physiol 1999;277:C183–201.
  • Trojanowska M, LeRoy EC, Eckes B, Krieg T. Pathogenesis of fibrosis: type I collagen and the skin. J Mol Med 1998;76:266–74.
  • Lawrance IC, Maxwell L, Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflammatory Bowel Dis 2001;7:226–36.
  • Hashimoto S, Gon Y, Takeshita I, Maruoka S, Horie T. IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway. J Allergy Clin Immunol 2001;107: 1001–8.
  • Smith S, Levi-Schaffer F. Mast cell-eosinophil-fibroblast crosstalk in allergic inflammation. In: Robinson DS, editor. Immunological mechanisms in asthma and allergic diseases. Chem Immunol London: Karger; 2000. p. 78, 81–92.
  • Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996;28:1–13.
  • Xu X, Weksler-Zangen S, Pikarsky A, Pappo O, Wengrower D, Bischoff SC, et al. Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis. Scand J Gastroenterol 2002;37:330–7.
  • Ruger B, Dunbar PR, Hasan Q, Sawada H, Kittelberger R, Greenhill N, et al. Human mast cells produce type VIII collagen in vivo. Int J Exp Path 1994;75:397–404.
  • Thompson HL, Burbelo PD, Gabriel G, Yamada Y, Metcalfe DD. Murine mast cells synthesize basement membrane components. A potential role in early fibrosis. J Clin Invest 1991; 87: 619–23.
  • Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors α and β in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996;110:975–84.
  • Bischoff SC, Grabowsky J, Manns MP. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 1997;42:394–403.
  • Raithel M, Matek M, Baenkler HW, Jorde W, Hahn EG. Mucosal histamine content and histamine secretion in Crohn’s disease, ulcerative colitis and allergic enterpathy. Int Arch Allergy Immunol 1995;108:127–33.
  • Weller PF. Human eosinophils. J Allergy Clin Immunol 1997; 100:283–7.
  • Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastrointestinal eosinophils. Immunol Rev 2001;179:139–55.
  • Dubucquoi S, Janin A, Klein O, Desreumaux P, Quandalle P, Cortot A, et al. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn’s disease. Gut 1995;37:242–6.
  • Bischoff SC, Mayer J, Nguyen QT, Stolte M, Manns MP. Immunohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel diseases. Am J Gastroenterol 1999;94:3521–9.
  • WinterKamp S, Raithel M, Hahn EG. Secretion and tissue content of eosinophil cationic protein in Crohn’s disease. J Clin Gastroenterol 2000;30:170–5.
  • Jeziorska M, Haboubi N, Schofield P, Woolley DE. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J Pathol 2001;194:484–92.
  • Carvalho AT, Elia CC, de Souza HS, Elias PR, Pontes EL, Lukashok HP, et al. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol 2003;36:120–5.
  • Nilsson G, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield JH, Sundstrom C, et al. Phenotypic characterization of the human mast cell line HMC-1. Scand J Immunol 1994;39: 489–98.
  • Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA 1999;96:8080–5.
  • Levi-Schaffer F, Garbuzenko E, Rubin A, Reich R, Pickholz D, Gillery P, et al. Human eosinophils regulate human lung and skin-derived fibroblast properties in vitro: a role for transforming growth factor β (TGF-β). Proc Natl Acad Sci USA 1999;96: 9660–5.
  • Schwartz LB, Bradford TR. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J Biol Chem 1986;261:7372–9.
  • Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 1997;151:317–22.
  • Okazawa A, Kanai T, Watanabe M, Yamazaki M, Inoue N, Ikeda M, et al. Th1-mediated intestinal inflammation in Crohn’s disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement. Am J Gastroenterol 2002;97:3108–17.
  • Kontoyiannis D, Boulougouris G, Manoloukos M, Armaka M, Apostolaki M, Pizarro T, et al. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn’s-like inflammatory bowel disease. J Exp Med 2002;196:1563–74.
  • Kanai T, Watanabe M, Okazawa A, Sato T, Hibi T. Interleukin- 18 and Crohn’s disease. Digestion 2001;63: 37–42.
  • Chen W, Paulus B, Shu D, Wilson, Chadwick V. Increased serum levels of eotaxin in patients with inflammatory bowel disease. Scand J Gastroenterol 2001;36:515–20.
  • Xia HZ, Kepley CL, Sakai K, Chelliah J, Irani AM, Schwartz LB. Quantitation of tryptase, chymase, FcεR1α, and FcεR1γ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol 1995; 154: 5472–80.
  • Garbuzenko E, Nagler A, Pickholtz D, Gillery P, Reich R, Maquart FX, Levi-Schaffer F. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy 2002;32:237–46.
  • Xu X, Rivkind A, Pappo O, Pikarsky A, Levi-Schaffer F. Role of mast cells and myofibroblasts in human peritoneal adhesion formation. Ann Surg 2002;236:593–601.
  • Taniguchi S, Furukawa M, Kono T, Hisa T, Ishii M, Hamada T. Butylated hydroxyanisole blocks the inhibitory effects of tumor necrosis factor-alpha on collagen production in human dermal fibroblasts. J Dermatol Sci 1996;12:44–9.
  • Siwik DA, Chang DL, Colucci WS. Interleukin-1β and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 2000;86: 1259–65.
  • Fries KM, Blieden T, Looney RJ, Sempowski GD, Silvera MR, Willis RA, et al. Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 1994;72:283–92.
  • Otte JM, Rosenberg IM, Podolsky DK. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 2003;124:1866–78.
  • Jelaska A, Strehlow D, Korn JH. Fibroblast heterogeneity in physiological conditions and fibrotic disease. Springer Semin Immunopathol 1999;21:385–95.
  • Rogler G, Gelbmann CM, Vogl D, Brunner M, Scholmerich J, Falk W, et al. Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures. Scand J Gastroenterol 2001;36:389–98.
  • McKaig BC, Hughes K, Tighe PJ, Mahida YR. Differential expression of TGF isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am J Physiol 2002;288:C172–82.
  • Saito S, Tsuno NH, Sunami E, Hori N, Kitayama J, Kazama S, et al. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease. J Gastroenterol 2003;38:229–37.
  • Abe M, Kurosawa M, Ishikawa O, Miyachi Y. Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. J Allergy Clin Immunol 2000;106:S78–84.
  • Hernnas J, Sarnstrand B, Lindroth P, Peterson CG, Venge P, Malmstrom A. Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures. Eur J Cell Biol 1992;59:352–63.
  • Rochester CL, Ackerman SJ, Zheng T, Elias JA. Eosinophilfibroblast interactions. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol 1996; 156:4449–56.
  • Furuta GT, Ackerman SJ, Varga J, Spiess AM, Wang MY, Wershil BK. Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts. Clin Exp Immunol 2000;122:35–40.
  • Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001;98:6162–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.